RRS1 and breast carcinoma: Because apoptosis inhibition is one of the causes of cisplatin resistance [15,16], exploring the relationship between RRS1 and cisplatin resistance in breast cancer cells may determine the potential of ribosomal proteins as therapeutic targets.